Serological assessment of gastric mucosal atrophy in gastric cancer. - Wikidata - awgldk - TriplyDB

Serological assessment of gastric mucosal atrophy in gastric cancer.

Serological assessment of gastric mucosal atrophy in gastric cancer.

http://www.wikidata.org/entity/Q34145097

about

Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection Generation of monoclonal antibody MS17-57 targeting secreted alkaline phosphatase ectopically expressed on the surface of gastrointestinal cancer cells Gastric mucosal status in populations with a low prevalence of Helicobacter pylori in Indonesia.The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research Virulence genes of Helicobacter pylori in the Dominican Republic.Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer Prevalence of Helicobacter pylori infection and atrophic gastritis in patients with dyspeptic symptoms in Myanmar.The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China Short term micronutrient-antioxidant supplementation has no impact on a serological marker of gastric atrophy in Zambian adults: retrospective analysis of a randomised controlled trial.Identification of Helicobacter pylori infection in symptomatic patients in Surabaya, Indonesia, using five diagnostic tests.Molecular Epidemiology of Helicobacter pylori Infection in Nepal: Specific Ancestor Root Helicobacter pylori Infection in Thailand: A Nationwide Study of the CagA Phenotype.Rare Helicobacter pylori Virulence Genotypes in Bhutan Helicobacter pylori virulence genes in the five largest islands of Indonesia The Diagnostic Value of Gastrin-17 Detection in Atrophic Gastritis: A Meta-Analysis Seroprevalence of Helicobacter pylori infection and gastric mucosal atrophy in Bhutan, a country with a high prevalence of gastric cancer Gastric adenocarcinoma in Zambia: a case-control study of HIV, lifestyle risk factors, and biomarkers of pathogenesis.Helicobacter pylori: gastric cancer and extragastric intestinal malignancies.Engineering bioinspired bacteria-adhesive clay nanoparticles with a membrane-disruptive property for the treatment of Helicobacter pylori infection.Helicobacter pylori virulence genes of minor ethnic groups in North Thailand.Noninvasive prediction of chronic atrophic gastritis in autoimmune thyroid disease in primary care.Nepalese Helicobacter pylori Genotypes Reflects a Geographical Diversity than a True Virulence Factor Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis.A comprehensive evaluation of fasting serum gastrin-17 as a predictor of diseased stomach in Chinese population.Gastric juice miR-129 as a potential biomarker for screening gastric cancer.MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives

P2860

Q28070185-51D83288-1C09-4EF2-B1BB-6BE8D28BE3A3 Q28534405-06D749DA-5CBA-41F2-9B31-6C788C11855A Q33626437-64AFFF0C-CDFD-428D-A6CF-911FF4A6ABEF Q33921574-520BE07E-1CB0-43E7-904E-09DB48CA77D8 Q34073186-08BA62EC-DB32-439C-86B2-E48397AF3EAF Q34721664-8A4E320B-E90C-4A81-BCF2-E69C24A20DAD Q34974132-35D5BE90-A42B-48C6-97A1-E3E207B0D989 Q35079534-CF01D641-53F8-4DEF-A63F-AD59A5A4585D Q35130622-B8E8C4D8-F8E6-4B29-B3B7-677507749B7C Q35208525-4DB7E952-4A99-40F5-A40F-CC3E0ECF65D3 Q35726552-3B25E95A-D9A0-44F2-BAB5-2AA20A6EE494 Q35769002-FB6791FA-5101-43E7-9A8A-DD038E62C426 Q35941817-EE753A64-B4B5-4D4A-AEEE-68178593800E Q36125580-04676B78-CB72-44F5-AA73-7B53A624875E Q36891967-454FDDB1-DB54-4ADC-AADE-6BD21FBD05BB Q37236092-6B4630BC-55AA-4908-B736-610FCE74CF98 Q37274450-58F29BC8-DA38-4CCD-A948-5DA49DFC5A40 Q38041643-FA849C40-90A7-46F6-8ADE-52C24E269111 Q40548402-0B56744D-851E-43C4-B557-089C9C064DDA Q42375188-3626EAF1-CCFB-4E1E-BE77-1F50520FBF90 Q43533385-FDBC3817-C407-4A5E-8B2C-D917483E240F Q47715521-AEBA7240-7BD7-4DAF-8C89-8041D214F5DD Q47985401-3B564826-ECB7-4020-B733-1209F79E5628 Q51316793-805DACD8-64D7-4B5E-860B-0B81EB8E1D81 Q54276195-8BFD4011-A463-4B2E-BDB1-CAA52587ABD8 Q57169572-5F3454A5-E961-4F77-9604-7F5F0F96D118

P2860

Serological assessment of gastric mucosal atrophy in gastric cancer.

http://www.wikidata.org/entity/Q34145097

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Serological assessment of gastric mucosal atrophy in gastric cancer.

@ast

Serological assessment of gastric mucosal atrophy in gastric cancer.

@en

Serological assessment of gastric mucosal atrophy in gastric cancer.

@nl

type

label

Serological assessment of gastric mucosal atrophy in gastric cancer.

@ast

Serological assessment of gastric mucosal atrophy in gastric cancer.

@en

Serological assessment of gastric mucosal atrophy in gastric cancer.

@nl

prefLabel

Serological assessment of gastric mucosal atrophy in gastric cancer.

@ast

Serological assessment of gastric mucosal atrophy in gastric cancer.

@en

Serological assessment of gastric mucosal atrophy in gastric cancer.

@nl

P1433

Q34145097-2E658D55-1D68-416C-B852-2B04AA99D73F

P1476

Q34145097-7C849E60-C80A-4716-9CD3-A552ECFF4788

P2093

Q34145097-414203E6-D2D2-4823-A62D-2680529C25D1

Q34145097-C88DAB10-44A7-4684-8FC4-26D7F29E384C

Q34145097-F724D761-E33F-434A-8B50-1926CCC25DD3

Q34145097-F7B1D8E5-DB6C-42C8-B72C-2D23E1912371

P2860

Q34145097-1033CF71-A0D4-47E7-BAA6-FF885DDB4676

Q34145097-122A0725-CC49-4C63-B6F9-907F3A562B2F

Q34145097-139C35C1-44C6-4090-845E-A866161A2F46

Q34145097-15192E32-3316-43A4-8EAF-C88B38089143

Q34145097-1B46AF28-D398-41A0-BF90-100F0AF384E1

Q34145097-1D2CBB1E-6258-4EEA-8EBE-ED45F66237FE

Q34145097-1FEA3888-6FA8-4D88-B5ED-D2F882077AE1

Q34145097-22F4D2C4-C84B-4BA0-833A-048BE148E79C

Q34145097-23559D61-5C1A-4039-90B8-C636E9E56D10

Q34145097-28FA079D-74D1-4538-802C-3ACFF00D06D2

P2888

Q34145097-6084574F-3797-4864-9677-E8DD5E43BE65

P304

Q34145097-9C643E38-6323-4A8B-A3FB-EE117A3E4429

P31

Q34145097-1FDEC954-1D9D-4774-AF30-2CBB007B218B

P356

Q34145097-CDF6A0A8-7CF6-4025-B526-B1CB8F470AFC

P478

Q34145097-DD5E74BA-FBB4-4E2B-8024-ECAC0ECADE83

P50

Q34145097-914AAEDC-4BB1-4AAD-A909-F87EB43B8682

P577

Q34145097-E5AA1681-45AE-41B5-9905-167A960CE78E

P6179

Q34145097-F2784D3C-CF60-42C6-A76E-678EDBF99F13

P698

Q34145097-8A0D8F7C-F0FE-421C-8E1C-5B8B665EAE08

P932

Q34145097-A791481A-A5DA-4840-A1D7-AC1061339E71

P356

1471-230X-12-10

P1433

BMC Gastroenterology

P1476

Serological assessment of gastric mucosal atrophy in gastric cancer.

@en

P2093

Doerthe Kuester

http://www.w3.org/2001/XMLSchema#string

Jan Bornschein

http://www.w3.org/2001/XMLSchema#string

Michael Selgrad

http://www.w3.org/2001/XMLSchema#string

Thomas Wex

http://www.w3.org/2001/XMLSchema#string

P2860

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portu

Higher number of Helicobacter pylori CagA EPIYA C phosphorylation sites increases the risk of gastric cancer, but not duodenal ulcer.

Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.

Classification of adenocarcinoma of the oesophagogastric junction.

Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort.

Accuracy of screening for gastric cancer using serum pepsinogen concentrations

Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study

Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry.

Gastritis staging in clinical practice: the OLGA staging system

Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status

P2888

1471-230x-12-10

P304

10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-230X-12-10

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Peter Malfertheiner

P577

2012-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1009170824

http://www.w3.org/2001/XMLSchema#string

P698

22289789

http://www.w3.org/2001/XMLSchema#string

P932

3280182

http://www.w3.org/2001/XMLSchema#string